GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Camp4 Therapeutics Corp (NAS:CAMP) » Definitions » Total Payout Yield %

CAMP (Camp4 Therapeutics) Total Payout Yield % : -216.42 (As of Apr. 17, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Camp4 Therapeutics Total Payout Yield %?

Total Payout Yield % is the percent a company has paid to its shareholders through net repurchases of shares and dividends based on its Market Cap. It is a measure of shareholder return.

Camp4 Therapeutics's current Total Payout Yield % is -216.42%.


Camp4 Therapeutics Total Payout Yield % Historical Data

The historical data trend for Camp4 Therapeutics's Total Payout Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Camp4 Therapeutics Total Payout Yield % Chart

Camp4 Therapeutics Annual Data
Trend Dec22 Dec23 Dec24
Total Payout Yield %
- - -72.55

Camp4 Therapeutics Quarterly Data
Dec22 Sep23 Dec23 Jun24 Sep24 Dec24
Total Payout Yield % Get a 7-Day Free Trial - - - - -290.08

Competitive Comparison of Camp4 Therapeutics's Total Payout Yield %

For the Biotechnology subindustry, Camp4 Therapeutics's Total Payout Yield %, along with its competitors' market caps and Total Payout Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Camp4 Therapeutics's Total Payout Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Camp4 Therapeutics's Total Payout Yield % distribution charts can be found below:

* The bar in red indicates where Camp4 Therapeutics's Total Payout Yield % falls into.


;
;

Camp4 Therapeutics Total Payout Yield % Calculation

Total Payout Yield % is a measure of shareholder return.

Camp4 Therapeutics's Total Payout Yield % for the fiscal year that ended in Dec. 2024 is calculated as

Total Payout Yield %=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Market Cap
=- (0 + 76.353 + 0) / 105.24042
=-72.55%

Camp4 Therapeutics's annualized Total Payout Yield % for the quarter that ended in Dec. 2024 is calculated as

Total Payout Yield %=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) * Annualized Factor / Market Cap
=- (0 + 76.32 + 0) * 4 / 105.24042
=-290.08%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Camp4 Therapeutics Total Payout Yield % Explanation

Similar to Dividend Yield, Total Payout Yield % is a measurement of shareholder return. Dividends is not the only way that companies are able to distribute their excess cash back to the shareholders. The other way to distribute the cash is a stock repurchase. The stock repurchase buys back the company's own shares from the marketplace. This results in a reduced number of oustanding shares, making each share worth a greater percentage of the corporation.


Camp4 Therapeutics Total Payout Yield % Related Terms

Thank you for viewing the detailed overview of Camp4 Therapeutics's Total Payout Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Camp4 Therapeutics Business Description

Traded in Other Exchanges
N/A
Address
One Kendall Square, Building 1400 West, 3rd Floor, Cambridge, MA, USA
Camp4 Therapeutics Corp is a clinical-stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics to upregulate gene expression and restore healthy protein levels to treat various genetic diseases. It focuses on genetic diseases of the central nervous system and liver. The group's pipeline products are CMP-CPS-001 and CMP-SYNGAP.